QQ客服 官方微博 反馈留言

	A Phase1b Dose Escalation Study of Recombinant Circularly Permuted TRAIL in Patients With Relapsed or Refractory Multiple Myeloma
	Hou, Jian; Qiu, Lugui; Zhao, Yaozhong; Zhang, Xuejun; Liu, Yan; Wang, Zhao; Zhou, Fang; Leng, Yun; Yang, Shifang; Xi, Hao
	2018
卷号	41期号:10页码:1008-1014
关键词	recombinant circularly permuted TRAIL multiple myeloma phase 1 safety pharmacokinetics
ISSN号	0277-3732
DOI	10.1097/COC.0000000000000404
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6346920
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Hou, Jian,Qiu, Lugui,Zhao, Yaozhong,et al. A Phase1b Dose Escalation Study of Recombinant Circularly Permuted TRAIL in Patients With Relapsed or Refractory Multiple Myeloma[J],2018,41(10):1008-1014.
APA	Hou, Jian.,Qiu, Lugui.,Zhao, Yaozhong.,Zhang, Xuejun.,Liu, Yan.,...&Zheng, Xiangjun.(2018).A Phase1b Dose Escalation Study of Recombinant Circularly Permuted TRAIL in Patients With Relapsed or Refractory Multiple Myeloma.,41(10),1008-1014.
MLA	Hou, Jian,et al."A Phase1b Dose Escalation Study of Recombinant Circularly Permuted TRAIL in Patients With Relapsed or Refractory Multiple Myeloma".41.10(2018):1008-1014.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。